Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Biomedicines|March 28, 2025
From Metabolic Syndrome to Cardio-Kidney-Metabolic Syndrome in the SIMETAP Study: Prevalence Rates of Metabolic Syndrome and Its Independent Associations with Cardio-Renal-Metabolic Disorders Other than Its Defining CriteriaAntonio Ruiz-García, Ezequiel Arranz-Martínez, Adalberto Serrano-Cumplido, et al.
Frontiers in Cardiovascular Medicine|May 25, 2023
Elevated pulse pressure and cardiovascular risk associated in Spanish population attended in primary care: IBERICAN studyAna Moyá-Amengual, Antonio Ruiz-García, Vicente Pallarés-Carratalá, et al.
Medicina (Kaunas, Lithuania)|October 28, 2023
Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140/90 or 130/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN StudyVicente Pallarés-Carratalá, Antonio Ruiz-García, Adalberto Serrano-Cumplido, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|October 5, 2016
Delphi consensus on the diagnosis and management of dyslipidaemia in chronic kidney disease patients: A post hoc analysis of the DIANA studyAleix Cases Amenós, Juan Pedro-Botet Montoya, Vicente Pascual Fuster, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 13, 2016
Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA StudyJesús Millán Núñez-Cortés, Aleix Cases Amenós, Juan Francisco Ascaso Gimilio, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|June 23, 2024
Comparison of baseline clinical characteristics among people with type 2 diabetes on second-line therapy previously added with dapagliflozin or another oral glucose-lowering drug: AGORA studyVicente Pallarés-Carratalá, Antonio Ruiz-García, Adalberto Serrano-Cumplido, et al.
Pageof 2